Project Portfolio

Frontier Science collaborates with a diverse group of highly respected global research partners to advance the scientific and medical communities’ understanding of various diseases and, ultimately, change lives.

ACTG
ACTG is a global clinical trials network federally funded program that supports the largest network of HIV/AIDS researchers and clinical trial units in the world
International Maternal Pediatric Adolescent AIDS Clinical Trials Network
IMPAACT conducts clinical trials to treat and prevent HIV infection in infants, children, adolescents, and pregnant/postpartum women
Pediatric HIV/AIDS Cohort Study
PHACS investigates the long-term effects of HIV and antiretroviral medications in children and young adults who were born with or born exposed to HIV
Cancer Prevention Clinical Trials Network
CP-CTNet early phase clinical trials assess safety, tolerability, and cancer prevention potential of agents and interventions
‘CASCADE’
‘CASCADE’ conducts pragmatic clinical trials to optimize the cervical cancer screening, management, and precancer treatment cascade for women living with HIV
CPQA
CPQA develops and conducts quality assurance activities in support of HIV translational research and clinical trial networks
ETOP-IBCSG
ETOP IBCSG pursues and maintains leading scientific research in thoracic malignancies and breast cancer while promoting and conducting international clinical research
OlympiA
OlympiA investigates the efficacy and safety of olaparib as an adjuvant treatment in patients with germline BRCA1/2 mutations and who are at high risk for HER2 negative primary breast cancer
RePORT International
The TB-RICC supports and coordinates research being conducted on tuberculosis control and prevention through TB-RePORT International and its networks